Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Coronaviruses
  4. Volume 6, Issue 1
  5. Article
Volume 6, Issue 1
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Objective

Some pregnancies are affected by liver dysfunction, and differentiating them from possible liver dysfunction caused by COVID-19 in pregnancy will lead to a better therapeutic approach and management.

Aims

The current study was conducted with the aim of investigating changes in liver function tests (LFTs) in pregnant women with mild and severe COVID-19.

Methods

In this retrospective observational study, 130 pregnant women with COVID-19 were examined in two referral hospitals in Iran in 2021-2022. COVID-19 was confirmed by reverse transcription-polymerase chain reaction (RT-PCR) and WHO guidelines. Pregnant women were assigned into two categories of mild and severe COVID-19 based on clinical symptoms and radiologic chest evaluation. Demographic and clinical data of women were recorded. The level of liver enzymes AST, ALT, ALP, total and direct bilirubin was measured in all patients. Fever, oxygen saturation level, preterm delivery, and maternal mortality were reported as final clinical outcomes and compared in two groups.

Results

Forty-nine pregnant women with severe COVID-19 and 81 pregnant women with mild COVID-19 were matched in terms of demographic data. The proportion of women with abnormal AST and ALT in the severe COVID-19 group was significantly higher than in the mild group ( < 0.05). However, the proportion of women with abnormal ALP levels in the mild COVID-19 group was significantly higher than in the severe group. Moreover, there was no significant difference between the two groups in terms of the proportion of women with abnormal levels of total and direct bilirubin. Most pregnant women with severe COVID-19 (50%) had a hepatocellular abnormality, while most women with mild COVID-19 (42%) had abnormalities in cholestasis ( = 0.003).

Conclusion

According to the present findings, liver dysfunction and increased liver enzymes in pregnant women with COVID-19 were related to the severity of the disease, and most women with severe COVID-19 had hepatocellular abnormality, respectively. Therefore, pregnant women with COVID-19 should be closely monitored for LFTs assessment.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/covid/10.2174/0126667975289100240216115702
2024-02-28
2025-01-06

  • From This Site

    /content/journals/covid/10.2174/0126667975289100240216115702
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. UshidaT. KotaniT. KinoshitaF. Liver transaminase levels during pregnancy: A Japanese multicenter study.J. Matern. Fetal Neonatal Med.202235255761576710.1080/14767058.2021.1892633 33645409
     [Google Scholar]
  2. TeodorescuC. ȘandruF. CharkaouiA. TeodorescuA. PopaA. MironA.I. The dynamic changes in the pattern of liver function tests in pregnant obese women.Exp. Ther. Med.202122398610.3892/etm.2021.10418 34345268
     [Google Scholar]
  3. ArabM. MirkheshtiA. NoghabaeiG. AshoriA. GhasemiT. Mostafa Hosseini-ZijoudS. The effect of premenstrual syndrome and menstrual phase on postoperative pain.Anesth. Pain Med.201552e1933310.5812/aapm.19333 25893183
     [Google Scholar]
  4. Conde-AgudeloA. RomeroR. SARS-CoV-2 infection during pregnancy and risk of preeclampsia: A systematic review and meta-analysis.Am. J. Obstet. Gynecol.202222616889.e310.1016/j.ajog.2021.07.009 34302772
     [Google Scholar]
  5. Jassim MohammedM. MuradS. Intake and output evaluation in post-surgical patients during ICU stay.Novel Clin Med202324170179
     [Google Scholar]
  6. ChenH. GuoJ. WangC. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records.Lancet20203951022680981510.1016/S0140‑6736(20)30360‑3 32151335
     [Google Scholar]
  7. CanE. OğlakS.C. ÖlmezF. Abnormal liver function tests in pregnant patients with COVID-19 — a retrospective cohort study in a tertiary center.Ginekol. Pol.202293215115710.5603/GP.a2021.0182 35072238
     [Google Scholar]
  8. HikmetF. MéarL. EdvinssonÅ. MickeP. UhlénM. LindskogC. The protein expression profile of ACE2 in human tissues.Mol. Syst. Biol.2020167e961010.15252/msb.20209610 32715618
     [Google Scholar]
  9. HammingI. TimensW. BulthuisM.L.C. LelyA.T. NavisG.J. van GoorH. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.J. Pathol.2004203263163710.1002/path.1570 15141377
     [Google Scholar]
  10. MarjotT. MoonA.M. CookJ.A. Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study.J. Hepatol.202174356757710.1016/j.jhep.2020.09.024 33035628
     [Google Scholar]
  11. YipT.C.F. LuiG.C.Y. WongV.W.S. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19.Gut202170473374210.1136/gutjnl‑2020‑321726 32641471
     [Google Scholar]
  12. WannerN. AndrieuxG. Badia-i-MompelP. Molecular consequences of SARS-CoV-2 liver tropism.Nat. Metab.20224331031910.1038/s42255‑022‑00552‑6 35347318
     [Google Scholar]
  13. CaiQ. HuangD. YuH. COVID-19: Abnormal liver function tests.J. Hepatol.202073356657410.1016/j.jhep.2020.04.006 32298767
     [Google Scholar]
  14. SunG. ZhangY. LiaoQ. ChengY. Blood test results of pregnant COVID-19 patients: An updated case-control study.Front. Cell. Infect. Microbiol.20201056089910.3389/fcimb.2020.560899 33117727
     [Google Scholar]
  15. RasmussenS.A. JamiesonD.J. COVID-19 and Pregnancy.Infect. Dis. Clin. North Am.202236242343310.1016/j.idc.2022.01.002 35636908
     [Google Scholar]
  16. GovilV. RashmiR. RituR. RaniA. PuhalS. BajajN. Anesthetic management of a pregnant patient with uncontrolled hyperthyroidism for emergency caesarean section: A case report.Novel Clin Med202323163167
     [Google Scholar]
  17. CunninghamF.G. Williams obstetrics.New YorkMcGraw-Hill Medical2022
     [Google Scholar]
  18. ChaiX. HuL. ZhangY. HanW. LuZ. KeA. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019- nCoV infection.bioRxiv202010.1101/2020.02.03.931766
     [Google Scholar]
  19. BertoliniA. van de PeppelI.P. BodewesF.A.J.A. Abnormal liver function tests in patients with COVID‐19: Relevance and potential pathogenesis.Hepatology20207251864187210.1002/hep.31480 32702162
     [Google Scholar]
  20. FanZ. ChenL. LiJ. Clinical features of COVID-19-related liver functional abnormality.Clin. Gastroenterol. Hepatol.20201871561156610.1016/j.cgh.2020.04.002 32283325
     [Google Scholar]
  21. ZhangC. ShiL. WangF.S. Liver injury in COVID-19: Management and challenges.Lancet Gastroenterol. Hepatol.20205542843010.1016/S2468‑1253(20)30057‑1 32145190
     [Google Scholar]
/content/journals/covid/10.2174/0126667975289100240216115702
Loading
Comparison of Changes in Liver Function Tests in Pregnant Women with Mild and Severe COVID-19
Coronaviruses 6, E280224227520 (2025); https://doi.org/10.2174/0126667975289100240216115702
/content/journals/covid/10.2174/0126667975289100240216115702
/content/journals/covid/10.2174/0126667975289100240216115702
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): bilirubin; COVID-19; LFTs assessment; liver function tests; pregnancy; SARS-CoV-2
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test